ABT-202
ABT-202 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors and has been researched for use as an analgesic, although it has not passed clinical trials.
primaryTopic
ABT-202
ABT-202 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors and has been researched for use as an analgesic, although it has not passed clinical trials.
has abstract
ABT-202 is a drug developed by ...... as not passed clinical trials.
@en
CAS number
309959-34-0
IUPAC name
(R)-1-(pyridin-3-yl)pyrrolidin-3-amine
@en
PubChem
thumbnail
Wikipage page ID
24,510,894
Wikipage revision ID
713,191,051
ChemSpiderID
16,397,614
molecular weight
1.63219e+2
smiles
StdInChIKey
LVGMMVAWLISWJD-MRVPVSSYSA-N
verifiedrevid
399,345,416
hypernym
comment
ABT-202 is a drug developed by ...... as not passed clinical trials.
@en
label
ABT-202
@en
